Clinical Evaluation of Free PSA/Total PSA (Prostate-specific Antigen) Ratio in the Diagnosis of Prostate Cancer

By Filella X.   Alcover J.   Molina R.   Rodriguez A.   Carretero P.   Ballesta A.M.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1226-1229

Elsevier

Access to resources Recommend Favorite

Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1–10.0 ng/ml at population screening

By Kitagawa Yasuhide   Ueno Satoru   Izumi Kouji   Kadono Yoshifumi   Konaka Hiroyuki   Mizokami Atsushi   Namiki Mikio  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 53-59

Springer Publishing Company

Access to resources Recommend Favorite

Is tumor vascularity in prostate core biopsies a predictor of PSA recurrence after radical prostatectomy?

By Khatami Ali   Pihl Carl-Gustaf   Norrby Klas   Hugosson Jonas   Damber Jan-Erik  

Acta Oncologica, Vol. 44, Iss. 4, 2005-06 ,pp. : 362-368

Informa Healthcare

Access to resources Recommend Favorite

A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy

By                    

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 819-824

Spandidos Publications

Access to resources Recommend Favorite

The utility of free to total PSA ratio for detecting prostate cancer in Japanese men with total PSA between 2.1 and 10 ng/ml - influence of total PSA, prostate volume, and age

By Ohori M.   Egawa S.   Koshiba K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 3, 1998-05 ,pp. : 80-85

Elsevier

Access to resources Recommend Favorite